Skip to main content

Table 1 Clinicopathological features (n = 155)

From: Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma

 

n

%

Age

  

   ≤ 45 years

61

39,4

   > 45 years

94

60,6

Tumor size

  

   ≤ 50 mm

118

76,1

   > 50 mm

37

23,9

Tumor grade

  

   1

17

11

   2

98

63,2

   3

40

25,8

Histologic type

  

   Ductal

130

83.8

   Non ductal

25

16.1

Lymph node

  

   Negative

90

58,1

   Positive

65

41,9

ER expression

  

   Negative

63

40,6

   Positive

92

59,4

PR expression

  

   Negative

73

47,1

   Positive

81

52,3

HER-2 status

  

   Negative (score 0, 1, 2+)

127

81,9

   Positive (score 3+)

28

18,1

Surgery

  

   MRM

88*

81.4*

   BCS

18*

16.6*

   MWAC

2*

1.8*

Systemic therapy

92*

85.1*

Radiotherapy

76*

70.3*

Hormone therapy

46*

42.5*

  1. HER-2: Human epidermal growth factor receptor 2; ER: Estrogen receptor; PR: Progesterone receptor; MRM: modified radical mastectomy; BCS: breast conserving surgery; MWAC: Mastectomy without axillary clearance. *: n = 108.
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us